Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Aarnoutse

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|January 27, 2006
Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosisRovina Ruslami, Hanneke Nijland, Rob Aarnoutse, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2025
Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber systemJelmer Raaijmakers, Rob Aarnoutse, Lindsey Te Brake, et al.
Tuberculosis (Edinburgh, Scotland)|December 24, 2023
Isoniazid exposures and acetylator status in Indonesian tuberculous meningitis patientsVycke Yunivita, Lindsey Te Brake, Sofiati Dian, et al.
Therapeutic Drug Monitoring|June 20, 2014
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settingsHadija H Semvua, Gibson S Kibiki, Elton R Kisanga, et al.
Expert Review of Clinical Pharmacology|November 27, 2018
Intensified antibiotic treatment of tuberculosis meningitisFiona V Cresswell, Lindsey Te Brake, Rachel Atherton, et al.
Expert Review of Respiratory Medicine|March 21, 2025
Treatment of nontuberculous mycobacterial pulmonary disease requires a stepwise and multidisciplinary approachArthur Lemson, Arjan van Laarhoven, Lisa Kurver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band DosingBudi O Susanto, Robin J Svensson, Elin M Svensson, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2020
Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin BRuth Van Daele, Yvo de Beer, Sander Croes, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|July 4, 2025
Medication adherence in patients with nontuberculous mycobacterial diseaseArthur Lemson, Fleur Dijkhuizen, Ralf Stemkens, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2013
Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patientsErlina Burhan, Carolien Ruesen, Rovina Ruslami, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|January 27, 2006
Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosisRovina Ruslami, Hanneke Nijland, Rob Aarnoutse, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2025
Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber systemJelmer Raaijmakers, Rob Aarnoutse, Lindsey Te Brake, et al.
Tuberculosis (Edinburgh, Scotland)|December 24, 2023
Isoniazid exposures and acetylator status in Indonesian tuberculous meningitis patientsVycke Yunivita, Lindsey Te Brake, Sofiati Dian, et al.
Therapeutic Drug Monitoring|June 20, 2014
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settingsHadija H Semvua, Gibson S Kibiki, Elton R Kisanga, et al.
Expert Review of Clinical Pharmacology|November 27, 2018
Intensified antibiotic treatment of tuberculosis meningitisFiona V Cresswell, Lindsey Te Brake, Rachel Atherton, et al.
Expert Review of Respiratory Medicine|March 21, 2025
Treatment of nontuberculous mycobacterial pulmonary disease requires a stepwise and multidisciplinary approachArthur Lemson, Arjan van Laarhoven, Lisa Kurver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band DosingBudi O Susanto, Robin J Svensson, Elin M Svensson, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2020
Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin BRuth Van Daele, Yvo de Beer, Sander Croes, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|July 4, 2025
Medication adherence in patients with nontuberculous mycobacterial diseaseArthur Lemson, Fleur Dijkhuizen, Ralf Stemkens, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2013
Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patientsErlina Burhan, Carolien Ruesen, Rovina Ruslami, et al.
Pageof 7